echinacea
Botanicalexperimental
Echinacea angustifolia, the narrow-leaved purple coneflower or blacksamson echinacea, is a species of flowering plant in the family Asteraceae. It is native to North America, where it is widespread across much of the Great Plains of central Canada and the central United States, with additional populations in surrounding regions. — Wikipedia
Clinical trial activity
24 trials · 38 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
8
Phase 3
6
Phase 4
7
Earliest trial started Jul 1, 1999 (NCT00689468)
Timeline
Indications
Approved for
Studied for
- Anxiety Disorders · Phase 2
- Carcinoma, Squamous Cell · Phase 2
- Carcinoma, Verrucous · Phase 2
- Common Cold · Phase 4
- COVID-19 · Phase 4
- Gastroenteritis · Phase 3
- Graft vs Host Disease · Phase 2
- Healthy Volunteers · Phase 4
- HIV · Phase 1
- HIV Infections · Phase 4
- Infections · Phase 4
- Mucositis · Phase 2
- Otitis Media · Phase 3
- Pharyngitis · Phase 3
- Respiratory Tract Infections · Phase 4
- Squamous Cell Carcinoma of Head and Neck · Phase 2
- Tongue Neoplasms · Phase 2
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaEchinacea angustifolia ↗
- NCATS4N9P6CC1DX ↗
- ChEMBLCHEMBL4297943 ↗
- ChEMBLCHEMBL2109053 ↗
- WikipediaEchinacea purpurea ↗
- WikipediaEchinacea ↗
Also known as
- echinacea
- echinacea
- echinacea
- echinacea angustifolia
- echinacea angustifolia
- echinacea purpurea
- echinaforce
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04999098 | Phase 4 | Sep 30, 2021 | A. Vogel AG, Biodome Clinical, Clinical Research Centre CONVEX, Medical University of Graz, Medistat Ltd., Israel |
| NCT04981314 | Phase 4 | Jun 18, 2021 | Laboratoires Arkopharma, SALUD (Servicio Aragonés de Salud), Spain, University of Santiago de Compostela |
| NCT05242718 | N/A | Jan 10, 2021 | Dicentra Inc., Immunoflex Therapeutics Inc., University of British Columbia |
| NCT05002179 | Phase 4 | Nov 20, 2020 | A. Vogel AG, Biodome Clinical, Bodimed, Clinical Research Centre CONVEX, d.s.h. statistical services GmbH, Medistat Ltd., Israel, VITA Hospital |
| NCT03812900 | Phase 2/Phase 3 (Phase 3) | Nov 30, 2018 | Bioforce AG, Cantonal Hospital of St. Gallen, Labormedizinisches Zentrum Dr. Risch |
| NCT03463018 | Phase 2 | Jun 6, 2018 | EuroPharma, Inc., Simon Khechinashvili University |
| NCT03070314 | Phase 4 | Feb 20, 2017 | Bioforce AG, University of Zurich |
| NCT02971384 | Phase 3 | Nov 1, 2016 | Bioforce AG |
| NCT02345447 | Phase 3 | Oct 1, 2013 | University of Tuebingen |
| NCT01674374 | Phase 2 | May 1, 2013 | National Cancer Institute (NCI), State University of New York, Buffalo |
| NCT02134119 | N/A | Jan 1, 2012 | Texas Tech University, University of Georgia |
| NCT01347658 | Phase 1 | Apr 1, 2011 | Fundacio Lluita Contra la SIDA |
| NCT01396889 | N/A | May 1, 2010 | Hormozgan University of Medical Sciences |
| NCT01129128 | N/A | May 1, 2010 | National Center for Complementary and Integrative Health (NCCIH), University of Washington |
| NCT01046890 | Phase 4 | Jan 1, 2010 | Badalona Hospital Germans Trias i Pujol, IrsiCaixa, University of Barcelona |
| NCT01021995 | Phase 4 | Oct 1, 2009 | Bioforce AG |
| NCT00860795 | N/A | Mar 1, 2009 | National Center for Complementary and Integrative Health (NCCIH), University of Washington |
| NCT00773435 | N/A | Nov 1, 2008 | National Center for Complementary and Integrative Health (NCCIH), University of Washington |
| NCT00707902 | Phase 3 | Feb 1, 2006 | Bioforce AG |
| NCT00231218 | Phase 3 | Jan 1, 2006 | University of Rochester |
Showing 20 of 24 trials
Page 1 / 2
Organizations
Research & Development (38)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Center for Complementary and Integrative Health (NCCIH) | Government | 6 | 2 | 3 | 1999 |
| Bioforce AG | For profit | 5 | 5 | 2 | 2006 |
| University of Washington | Academic/Hospital | 4 | 3 | 2 | 2000 |
| A. Vogel AG | For profit | 2 | 2 | 1 | 2020 |
| Biodome Clinical | Academic/Hospital | 2 | 0 | 1 | 2020 |
| Clinical Research Centre CONVEX | For profit | 2 | 0 | 1 | 2020 |
| Medistat Ltd., Israel | For profit | 2 | 0 | 1 | 2020 |
| Badalona Hospital Germans Trias i Pujol | Academic/Hospital | 1 | 1 | 1 | 2010 |
| Bodimed | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Cantonal Hospital of St. Gallen | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Clemson University | Academic/Hospital | 1 | 0 | 1 | 2001 |
| Dicentra Inc. | For profit | 1 | 0 | 1 | 2021 |
| d.s.h. statistical services GmbH | For profit | 1 | 0 | 1 | 2020 |
| EuroPharma, Inc. | For profit | 1 | 1 | 1 | 2018 |
| Fundacio Lluita Contra la SIDA | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Hormozgan University of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2010 |
| Immunoflex Therapeutics Inc. | For profit | 1 | 1 | 1 | 2021 |
| IrsiCaixa | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Laboratoires Arkopharma | For profit | 1 | 0 | 1 | 2021 |
| Labormedizinisches Zentrum Dr. Risch | Academic/Hospital | 1 | 0 | 1 | 2018 |
38 organizations
Page 1 / 2